Common Side Effects of GLP-1 Medications

You’ve started a GLP-1 medication — or you’re about to — and you want to know what’s coming. Maybe you’ve already Googled it and found horror stories. Maybe someone in a Facebook group posted about being sick for three weeks straight. Maybe your pharmacist rattled off a list of warnings and you left more anxious than when you walked in.

Here’s what the clinical data actually shows: side effects are common, but they’re overwhelmingly mild, temporary, and manageable. The vast majority of people who start these medications stay on them — and the side effects that show up early tend to fade as your body adjusts.

This page is the big picture. We’ll cover what the most common side effects are, how often they actually happen, and why they tend to get better over time. The rest of this section goes deeper into each one — nausea management, GI issues, fatigue, injection site reactions, and more. Start here, then dig into whatever applies to you.


The GI Side Effects — The Ones Everyone Talks About

Let’s start with the elephant in the room: stomach issues. GLP-1 medications slow down how quickly food moves through your digestive system. That’s actually part of how they work — it helps you feel full longer and reduces appetite. But it also means your gut needs time to adjust, and during that adjustment period, things can get uncomfortable.

The most common side effects are:

Nausea — ~44% for semaglutide, ~24–31% for tirzepatide. The big one.[1][2]

Diarrhea — ~30% for semaglutide, ~19–23% for tirzepatide.[1][2]

Vomiting — ~25% for semaglutide, ~8–12% for tirzepatide.[1][2]

Constipation — ~24% for semaglutide, ~12–17% for tirzepatide.[1][2]

Abdominal pain — ~20% for semaglutide.[1]

Those percentages look high. And they are — side effects are genuinely common with these medications. But here’s the part that usually gets left out of the scary headlines:

99.5% of GI side effects in semaglutide trials were non-serious. And 98% were rated as mild to moderate.[1] We’re mostly talking about the kind of nausea where you don’t feel great for a few hours — not the kind where you’re in the emergency room.

From Brandon's Experience:

I’m not going to sugarcoat it — the first couple weeks on semaglutide, I felt queasy. Especially after eating too much or eating too fast (habits I hadn’t broken yet). But it was more like “I probably shouldn’t have had that second helping” nausea, not “I need to pull over the car” nausea. By week three or four, I barely noticed it. Your mileage will vary, but most people I’ve talked to describe a similar arc.


Beyond the Stomach — Other Common Side Effects

GI symptoms get all the attention, but there are a few other side effects worth knowing about:

Headache — ~14% for semaglutide (vs. 10% placebo — some of that is just... life). Tirzepatide: 4–11%.[3][4]

Fatigue — ~11% for semaglutide.[3] Makes sense — your body is adjusting to a significant change in how it processes energy.

Dizziness — ~8% for semaglutide.[3]

Injection site reactions — ~1–3%. Surprisingly uncommon. Very small needles — most people barely feel the injection.[3][4]

Hair thinning — ~3% for semaglutide, ~5–6% for tirzepatide.[2][3] Likely related to rapid weight loss (telogen effluvium), not the medication directly. Usually temporary.

From my experience, headaches were an issue for me in the first week or two. Turned out I wasn’t drinking nearly enough water — these medications can be dehydrating, especially if nausea is making you eat and drink less. Once I got serious about hydration, the headaches disappeared.


Why Side Effects Are Worst at the Beginning

There’s a pattern to GLP-1 side effects, and understanding it makes the whole experience less alarming.

These medications are prescribed using a dose escalation schedule. You start at a low dose and gradually increase over weeks or months until you reach the target dose. This isn’t optional or arbitrary — it exists specifically because jumping straight to the full dose would make side effects significantly worse. The slow climb gives your body time to adapt.

Here’s what the clinical data tells us about timing:

  1. Nausea peaks during dose escalation — for semaglutide, the highest rates were around week 20 (when most people are still titrating up), then declined steadily.[1]
  2. Episodes are short-lived — median nausea episode: 8 days. Diarrhea: 3 days. Vomiting: about 2 days.[1]
  3. Almost nobody quits after maintenance — in one large semaglutide trial, only 2 people discontinued due to GI side effects after week 20, out of hundreds of participants.[1]

The same pattern holds for tirzepatide. A pooled analysis of the SURMOUNT trials found that most GI events were “transient and occurred during dose escalation,” with anti-nausea medication use concentrated in the first 24 weeks.[5]

The takeaway: if you’re going to feel crummy, it’s almost always during the ramp-up. Once you’re at your maintenance dose and your body has adjusted, side effects typically settle down or disappear entirely.

Did You Know?

Clinical trials with slower, more gradual dose escalation schedules showed notably better side effect profiles than trials that ramped up faster. This is why your provider won’t rush you to the highest dose — and why you shouldn’t push to increase faster than prescribed.[5][6] Source: Rubino et al., Diabetes, Obesity and Metabolism, 2025; Trujillo et al., PMC, 2023


The Numbers That Actually Matter: How Many People Stop?

This is the question behind the question. You can handle some nausea if you know it’s temporary. What you really want to know is: do people actually quit because of side effects?

The answer: some do, but it’s a small minority.

MedicationGI Discontinuation RateContext
Semaglutide (Wegovy)4.3%vs. 0.7% on placebo[1]
Tirzepatide (Zepbound)4–7%Depending on dose[2]
SURMOUNT-5 (head-to-head)Tirzepatide 2.7% vs. semaglutide 5.6%Only direct comparison trial[7]

That means roughly 93-96% of people who start these medications are able to manage the side effects and stay on treatment. The side effects are real, but for the vast majority of people, they’re a speed bump — not a roadblock.


Nausea Doesn’t Equal Weight Loss

One myth worth addressing right here: some people believe that feeling nauseous is how the medication works — that being sick is what causes weight loss. That’s not how it works.

Clinical trial data shows that weight loss occurs independently of nausea and vomiting. People who didn’t experience GI side effects still lost significant weight. The real mechanisms are appetite reduction, slower gastric emptying, and changes in how your brain processes hunger and satiety signals — not feeling too sick to eat.[5]

This matters because it means if you find a way to manage your nausea effectively (and there are plenty of strategies — we cover them in the Nausea Management Guide), you’re not undermining your results. You’re just more comfortable while getting them.


A Note on Individual Variation

Everything on this page is based on clinical trial averages — large studies with thousands of participants. Your personal experience could be very different from the percentages above. Some people sail through with barely a hiccup. Others have a rougher adjustment period. Factors that can influence your experience include:

Which medication — tirzepatide generally has lower nausea rates than semaglutide in trials

Dose & escalation speed — slower escalation typically means fewer side effects

What & how you eat — large, heavy, or greasy meals make GI symptoms worse

Hydration — dehydration amplifies nausea, headaches, and fatigue

Individual biology — everyone's gut responds differently

The good news is that there’s a lot you can do to manage side effects when they show up. That’s what the rest of this section is for.


The Bottom Line

Side effects from GLP-1 medications are common — there’s no getting around that. But they’re also overwhelmingly mild, concentrated in the first few months of treatment, and manageable with the right strategies. The clinical data is clear: the vast majority of people who start these medications are able to stay on them.

If you’re about to start a GLP-1, don’t let the side effect list scare you off. Know what’s coming, have a plan for managing it, and give your body time to adjust. The rest of this section will give you the specific tools for each side effect — starting with Nausea Management, the one most people want to read first.

If you’re already on a GLP-1 and dealing with side effects, you’re not alone, and what you’re feeling is almost certainly normal. But if something feels wrong — not just uncomfortable, but genuinely concerning — check out When to Contact Your Doctor for the red flags that actually warrant a call.


Sources:

  1. Wharton, S., et al. “Gastrointestinal tolerability of once-weekly semaglutide 2.4 mg in adults with overweight or obesity.” Diabetes, Obesity and Metabolism, 2022.
  2. Jastreboff, A.M., et al. “Tirzepatide Once Weekly for the Treatment of Obesity.” New England Journal of Medicine, 2022.
  3. Novo Nordisk. “Wegovy (semaglutide) Prescribing Information.” FDA, 2025.
  4. Karagiannis, T., et al. “Adverse Events Related to Tirzepatide.” PMC, 2023.
  5. Rubino, D.M., et al. “Gastrointestinal tolerability and weight reduction associated with tirzepatide.” Diabetes, Obesity and Metabolism, 2025.
  6. Trujillo, J.M., et al. “Clinical Recommendations to Manage GI Adverse Events in Patients Treated with GLP-1 RAs.” PMC, 2023.
  7. American College of Cardiology. “SURMOUNT-5 Trial Results.” ACC Journal Scans, 2025.

Want to Start Tracking Your Progress?

Printable templates designed for people on GLP-1 medications — side effect trackers, progress logs, meal planners, and more.

View Templates